Atlantic Union Bankshares’s Standard BioTools LAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.65K Buy
2,000
+1,500
+300% +$1.42K ﹤0.01% 1555
2026
Q1
$460 Buy
500
+250
+100% +$303 ﹤0.01% 1633
2025
Q4
$320 Sell
250
-750
-75% -$1.01K ﹤0.01% 1620
2025
Q3
$1.3K Sell
1,000
-750
-43% -$983 ﹤0.01% 1509
2025
Q2
$2.1K Buy
+1,750
New +$1.94K ﹤0.01% 1082

Other funds holding LAB

Atlantic Union Bankshares's LAB Position: Q2 2026 in Review

Atlantic Union Bankshares increased its Standard BioTools (LAB) stake by 300% in Q2 2026, buying an estimated $1.42K and bringing the position to 2,000 shares worth $1.65K. The position accounts for ﹤0.01% of the portfolio, ranked #1555.

Atlantic Union Bankshares first reported a position in LAB in Q2 2025 and has held it in 5 quarters since. The position peaked at $2.1K in Q2 2025. 144 funds tracked by Wall St. Rank hold LAB as of Q2 2026.

  • Atlantic Union Bankshares held 2,000 shares of Standard BioTools worth $1.65K as of Q2 2026.
  • Atlantic Union Bankshares bought 1,500 Standard BioTools shares in Q2 2026, an estimated $1.42K.
  • Standard BioTools made up ﹤0.01% of Atlantic Union Bankshares's portfolio in Q2 2026, its #1555 holding.
  • Atlantic Union Bankshares first reported a position in Standard BioTools in Q2 2025 and has held it in 5 quarters since.
  • Atlantic Union Bankshares's Standard BioTools position peaked at $2.1K in Q2 2025.
  • 144 funds tracked by Wall St. Rank held Standard BioTools as of Q2 2026.

Based on Atlantic Union Bankshares's 13F filing for Q2 2026, filed 11 Aug 2026.